Items Tagged ‘Mark Ratain’

December 23, 2014

Don’t Change Breast Cancer Guidelines on Flawed Research

By Center for Individualized Medicine Center for Individualized Medicine (@samuelsmith5209)

    Clinical recommendations discouraging the use of CYP2D6 gene testing to guide tamoxifen therapy in breast cancer patients are based on studies with flawed methodology and should be reconsidered, according to the results of a Mayo Clinic study published in the Journal of the National Cancer Institute. For years, controversy has surrounded the CYP2D6 […]

View full entry

Tags: biomarker, biomarkers, cancer, center for individualized medicine, CYP2D6, DNA, DNA Sequencing, dna test, DNA Testing, gene sequencing, genome science, Genome Sequencing

Contact Us · Privacy Policy